Pharming (PHAR) Share-based Compensation (2020 - 2023)
Historic Share-based Compensation for Pharming (PHAR) over the last 4 years, with Q2 2023 value amounting to $4.0 million.
- Pharming's Share-based Compensation changed N/A to $4.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $8.0 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2021, which is 7079.7% down from last year.
- Latest data reveals that Pharming reported Share-based Compensation of $4.0 million as of Q2 2023.
- In the past 5 years, Pharming's Share-based Compensation ranged from a high of $4.0 million in Q2 2023 and a low of -$3.7 million during Q3 2021
- Its 4-year average for Share-based Compensation is $735318.6, with a median of $1.1 million in 2022.
- Over the last 5 years, Pharming's Share-based Compensation had its largest YoY gain of 2788672.95% in 2021, and its largest YoY loss of 54856.91% in 2021.
- Quarter analysis of 4 years shows Pharming's Share-based Compensation stood at $6821.1 in 2020, then soared by 27886.73% to $1.9 million in 2021, then plummeted by 43.95% to $1.1 million in 2022, then surged by 271.03% to $4.0 million in 2023.
- Its Share-based Compensation was $4.0 million in Q2 2023, compared to $1.1 million in Q4 2022 and $1.1 million in Q1 2022.